I6T-MC-AMAH - ClinicalTrials.gov - NCT03556202
I6T-MC-AMAH - ClinicalTrials.gov - NCT03556202
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed the last visit of an eligible study period of originating study
Participants must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential
Participants must NOT
Participants must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, liver, kidney, gastrointestinal, endocrine, blood, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study
Participants must not have stopped taking mirikizumab during a previous study if the study investigator does not think the participant should resume taking mirikizumab
Trial Summary
Conditions the trial is for
Psoriasis
What the trial is testing?
Mirikizumab
Could I receive a Placebo?
no
Enrollment Goal
1816
Trial Dates
September 2018 - May 2024
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participants must have completed the last visit of an eligible study period of originating study
Participants must be willing to follow the birth control measures during and after study treatment if woman of childbearing potential
Participants must NOT
Participants must not have an unstable or uncontrolled illness, including but not limited to a cerebro-cardiovascular, respiratory, liver, kidney, gastrointestinal, endocrine, blood, or neurologic disease or abnormal lab results, that the study investigator thinks makes it unsafe or inappropriate for the participant to participate in this study
Participants must not have stopped taking mirikizumab during a previous study if the study investigator does not think the participant should resume taking mirikizumab
Trial Summary
Conditions the trial is for
Psoriasis
What the trial is testing?
Mirikizumab
Could I receive a Placebo?
no
Enrollment Goal
1816
Trial Dates
September 2018 - May 2024
Trial Phase
3
Trial Locations
Hide locations not currently recruiting